Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevan C Herold

Showing results (1-10 of 239) with videos related to

Pageof 24
Sort By:
The Journal of Clinical Investigation|February 3, 2004
Achieving antigen-specific immune regulationKevan C Herold
Endocrinology and Metabolism Clinics of North America|April 1, 2004
Treatment of type 1 diabetes mellitus to preserve insulin secretionKevan C Herold
The Lancet. Diabetes & Endocrinology|March 14, 2014
Restoring immune balance in type 1 diabetesKevan C Herold
Current Diabetes Reports|July 22, 2004
Treatment of type 1 diabetes with anti-T-cell agents: from T-cell depletion to T-cell regulationMariela Glandt, Kevan C Herold
Nature Clinical Practice. Endocrinology & Metabolism|December 21, 2006
Islet transplantation for type 1 diabetes--where should we go?Piotr Witkowski, Kevan C Herold
Nature Clinical Practice. Endocrinology & Metabolism|August 26, 2006
Drug insight: New immunomodulatory therapies in type 1 diabetesSimona Cernea, Kevan C Herold
Immunologic Research|November 12, 2003
Treatment of Type 1 diabetes with anti-CD3 monoclonal antibody: induction of immune regulation?Kevan C Herold, Lesley Taylor
Human Immunology|September 27, 2008
Generation and function of human regulatory CD8+ T cells induced by a humanized OKT3 monoclonal antibody hOKT3gamma1 (Ala-Ala)Vitaly Ablamunits, Kevan C Herold
Diabetes/Metabolism Research and Reviews|March 26, 2009
Anti-CD3 mAbs for treatment of type 1 diabetesAdam Kaufman, Kevan C Herold
Cold Spring Harbor Perspectives in Medicine|June 8, 2012
Immunologic and metabolic biomarkers of β-cell destruction in the diagnosis of type 1 diabetesJasmin Lebastchi, Kevan C Herold
Pageof 24

Showing results (1-10 of 239) with videos related to

Sort By:
Pageof 24
The Journal of Clinical Investigation|February 3, 2004
Achieving antigen-specific immune regulationKevan C Herold
Endocrinology and Metabolism Clinics of North America|April 1, 2004
Treatment of type 1 diabetes mellitus to preserve insulin secretionKevan C Herold
The Lancet. Diabetes & Endocrinology|March 14, 2014
Restoring immune balance in type 1 diabetesKevan C Herold
Current Diabetes Reports|July 22, 2004
Treatment of type 1 diabetes with anti-T-cell agents: from T-cell depletion to T-cell regulationMariela Glandt, Kevan C Herold
Nature Clinical Practice. Endocrinology & Metabolism|December 21, 2006
Islet transplantation for type 1 diabetes--where should we go?Piotr Witkowski, Kevan C Herold
Nature Clinical Practice. Endocrinology & Metabolism|August 26, 2006
Drug insight: New immunomodulatory therapies in type 1 diabetesSimona Cernea, Kevan C Herold
Immunologic Research|November 12, 2003
Treatment of Type 1 diabetes with anti-CD3 monoclonal antibody: induction of immune regulation?Kevan C Herold, Lesley Taylor
Human Immunology|September 27, 2008
Generation and function of human regulatory CD8+ T cells induced by a humanized OKT3 monoclonal antibody hOKT3gamma1 (Ala-Ala)Vitaly Ablamunits, Kevan C Herold
Diabetes/Metabolism Research and Reviews|March 26, 2009
Anti-CD3 mAbs for treatment of type 1 diabetesAdam Kaufman, Kevan C Herold
Cold Spring Harbor Perspectives in Medicine|June 8, 2012
Immunologic and metabolic biomarkers of β-cell destruction in the diagnosis of type 1 diabetesJasmin Lebastchi, Kevan C Herold
Pageof 24